Skip to content

Review-State-Aware Comparison

Arctic Seaberry vs Bitter Gourd

An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.

This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.

Arctic Seaberry
Bitter Gourd
Category
Berry
Fruit
Public Score
10/10 (validated)
10/10 (validated)
Screened PMIDs
—
—
Entity Type
Compound
Compound
Overview
Arctic Seaberry (Hippophae rhamnoides) contains exceptionally high concentrations of isorhamnetin, quercetin, omega-7 fatty acids, and vitamin C that modulate PI3K/AKT/mTOR and Nrf2/HO-1 pathways for cellular protection. Clinical research demonstrates its bioactive compounds enhance immune function, skin regeneration, and metabolic regulation through antioxidant and anti-inflammatory mechanisms.
Bitter gourd (Momordica charantia) contains bioactive compounds including charantin, momordicosides, and MAP30 protein that regulate glucose metabolism through AMPK activation, GLUT4 translocation, and PTP1B inhibition—mechanisms validated in a 2020 meta-analysis demonstrating hypoglycemic efficacy in type 2 diabetes patients (PMID: 32951763). Beyond glycemic control, its cucurbitane triterpenoids and exosome-like nanovesicles show potent anticancer, cardioprotective, and anti-inflammatory activity, with 2024–2025 research revealing novel mechanisms including p62 stabilization against doxorubicin cardiotoxicity (PMID: 39095755) and intestinal microenvironment renovation in ulcerative colitis (PMID: 40170075).
Dosage
Withheld: no dosage-supported approval.
Withheld: no dosage-supported approval.

Human-Reviewed Benefit Text

Arctic Seaberry

Enhances immune resilience through its exceptionally high vitamin C and antioxidant content
Promotes skin hydration and regeneration, supported by omega-7 fatty acids and tocopherols
Supports metabolic regulation by influencing lipid and glucose metabolism
Strengthens cognitive clarity and neuroprotection with its rich profile of polyphenols and flavonoids
Contributes to cardiovascular health by improving vascular function and reducing oxidative stress
Modulates gut microbiome balance and aids digestive health via its prebiotic fiber content

Bitter Gourd

Regulates blood sugar levels by improving insulin sensitivity and glucose metabolism
Enhances liver detoxification by promoting bile production and reducing hepatic inflammation
Supports cardiovascular health by lowering LDL cholesterol and improving arterial flexibility
Fortifies immune function with antimicrobial and antiviral properties
Provides powerful antioxidant protection against oxidative stress and systemic inflammation
Aids digestive support and promotes gut microbiome balance

Human-Reviewed Mechanism Text

Arctic Seaberry

Isorhamnetin and quercetin modulate PI3K/AKT/mTOR, NF-κB, MAPK, and Wnt/β-catenin pathways to promote apoptosis via Bax upregulation and Bcl-2/Bax ratio changes. Sea buckthorn polysaccharides activate Nrf2/HO-1/SOD-2 pathways for antioxidant effects. Flavonoids (6.25–100 μM) upregulate PPAR-γ/α, ABCA1, and CPT1A to enhance cholesterol efflux and fatty acid oxidation while inhibiting SREBP-2/LDLR for improved lipid metabolism.

Bitter Gourd

Bitter gourd's primary hypoglycemic mechanism involves charantin and momordicosides activating AMP-activated protein kinase (AMPK) in skeletal muscle and liver tissue, which promotes translocation of glucose transporter type 4 (GLUT4) to the cell membrane for enhanced glucose uptake while simultaneously inhibiting hepatic gluconeogenesis. The protein tyrosine phosphatase 1B (PTP1B) enzyme—a negative regulator of insulin signaling—is directly inhibited by cucurbitane triterpenoids, thereby potentiating insulin receptor substrate (IRS-1) phosphorylation and downstream PI3K/Akt signaling. MAP30 (Momordica Anti-HIV Protein, 30 kDa), a ribosome-inactivating protein, exerts antitumor effects through topoisomerase inhibition, DNA repair impairment in cancer cells, and modulation of NF-κB and STAT3 signaling cascades (PMID: 26968675; PMID: 20198408). Additionally, bitter gourd–derived exosome-like nanovesicles stabilize the autophagy adaptor protein p62/SQSTM1, attenuating oxidative stress–induced cardiomyocyte apoptosis via the Keap1-Nrf2 antioxidant pathway (PMID: 39095755).

Human-Reviewed Safety Text

Arctic Seaberry:

Current research reports no adverse effects in animal models at tested doses up to 50 mg/kg, though comprehensive human safety data is limited. No specific drug interactions or contraindications have been identified in available studies, but this may reflect insufficient clinical investigation rather than confirmed safety. Pregnant and breastfeeding women should exercise caution due to lack of safety data in these populations. Individuals taking anticoagulant medications should consult healthcare providers, as high vitamin C content may theoretically affect blood clotting parameters.

Bitter Gourd:

Bitter gourd supplement may potentiate the hypoglycemic effects of insulin, metformin, sulfonylureas, and other antidiabetic medications, increasing the risk of clinically significant hypoglycemia; concurrent use requires blood glucose monitoring and potential dose adjustment. The fruit and its extracts have demonstrated hepatic CYP3A4 modulation in preclinical studies, which could theoretically alter the metabolism of drugs processed through this pathway, including statins, calcium channel blockers, and immunosuppressants. Bitter gourd is contraindicated during pregnancy due to abortifacient properties documented in animal models, and the seed extract vicine can cause favism-like hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. The 2020 meta-analysis by Kim et al. reported that Momordica charantia was generally well-tolerated at standard supplemental doses (1–6 g/day) but noted gastrointestinal adverse effects including abdominal pain and diarrhea in some participants (PMID: 32951763).

Comparison summary

This automated view does not establish that either Arctic Seaberry or Bitter Gourd is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.

Frequently Asked Questions

Is Arctic Seaberry or Bitter Gourd better?

Arctic Seaberry and Bitter Gourd have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.

Can you take Arctic Seaberry and Bitter Gourd together?

No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.

What is the main difference between Arctic Seaberry and Bitter Gourd?

Arctic Seaberry is categorized as berry (Compound), while Bitter Gourd is categorized as fruit (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.